Raymond James Financial Services Advisors, Inc. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2022$275,000
+22.2%
1,472
+6.4%
0.00%
Q2 2022$225,000
-37.7%
1,384
-27.8%
0.00%
-100.0%
Q1 2022$361,000
-38.4%
1,917
-13.3%
0.00%0.0%
Q4 2021$586,000
-26.8%
2,212
-20.2%
0.00%
-50.0%
Q3 2021$801,000
-32.9%
2,773
-53.6%
0.00%0.0%
Q2 2021$1,194,000
-20.3%
5,980
-22.4%
0.00%
-33.3%
Q1 2021$1,499,000
+3.7%
7,709
+2.2%
0.00%
-25.0%
Q4 2020$1,445,000
+464.5%
7,543
+334.3%
0.00%
+300.0%
Q3 2020$256,0001,7370.00%
Other shareholders
REPLIGEN CORP shareholders Q3 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders